JP2001522836A5 - - Google Patents

Download PDF

Info

Publication number
JP2001522836A5
JP2001522836A5 JP2000520420A JP2000520420A JP2001522836A5 JP 2001522836 A5 JP2001522836 A5 JP 2001522836A5 JP 2000520420 A JP2000520420 A JP 2000520420A JP 2000520420 A JP2000520420 A JP 2000520420A JP 2001522836 A5 JP2001522836 A5 JP 2001522836A5
Authority
JP
Japan
Prior art keywords
lower alkyl
phenyl
substituted
group
trihalomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000520420A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001522836A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/023225 external-priority patent/WO1999024406A1/en
Publication of JP2001522836A publication Critical patent/JP2001522836A/ja
Publication of JP2001522836A5 publication Critical patent/JP2001522836A5/ja
Pending legal-status Critical Current

Links

JP2000520420A 1997-11-07 1998-11-05 H3レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール Pending JP2001522836A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96626497A 1997-11-07 1997-11-07
US08/966,264 1997-11-07
PCT/US1998/023225 WO1999024406A1 (en) 1997-11-07 1998-11-05 Phenyl-alkyl-imidazoles as h3 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2001522836A JP2001522836A (ja) 2001-11-20
JP2001522836A5 true JP2001522836A5 (https=) 2006-01-05

Family

ID=25511129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520420A Pending JP2001522836A (ja) 1997-11-07 1998-11-05 H3レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール

Country Status (12)

Country Link
EP (1) EP1028948B1 (https=)
JP (1) JP2001522836A (https=)
CN (1) CN1285823A (https=)
AR (1) AR016416A1 (https=)
AT (1) ATE231841T1 (https=)
AU (1) AU1296899A (https=)
CA (1) CA2309121A1 (https=)
DE (1) DE69811110T2 (https=)
ES (1) ES2188029T3 (https=)
PE (1) PE130799A1 (https=)
WO (1) WO1999024406A1 (https=)
ZA (1) ZA9810184B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
AU2004274309B2 (en) 2003-09-22 2010-04-08 Msd K.K. Novel piperidine derivative
CA2550679A1 (en) * 2003-12-23 2005-07-14 Schering Corporation Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
AU2006204724A1 (en) 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
EP0920315B1 (en) * 1996-08-16 2005-12-28 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Similar Documents

Publication Publication Date Title
JP2001522836A5 (https=)
JP2004516314A5 (https=)
JP2005514366A5 (https=)
JP2003519676A5 (https=)
JP2007508359A5 (https=)
JP2005518357A5 (https=)
JP2006524225A5 (https=)
JP2005501120A5 (https=)
JP2010540593A5 (https=)
JP2011507929A5 (https=)
JP2001525411A5 (https=)
JP2010513448A5 (https=)
JP2006524222A5 (https=)
JP2007508362A5 (https=)
WO2002098857A8 (en) New indole derivatives with 5-ht6 receptor affinity
JP2006500394A5 (https=)
JP2005505618A5 (https=)
JP2002513793A5 (https=)
JP2007510662A5 (https=)
JP2010501478A5 (https=)
NO20080738L (no) Fremgangsmater for neurobeskyttelse
JP2005514420A5 (https=)
JP2006507355A5 (https=)
JP2002528493A5 (https=)
JP2002521334A5 (https=)